Hans Fredrik Mattsson

Hans Fredrik Mattsson

Director/Board Member bei DEVYSER DIAGNOSTICS AB

52 Jahre
Health Technology
Commercial Services
Finance

Profil

Hans Fredrik Mattsson is currently the Chairman at Celemi International AB, the Director at Dipylon Medical AB, the Director at Investment AB Bure, the Director at Bure Growth AB, and the Independent Director at Devyser Diagnostics AB.
Previously, he served as the Chief Executive Officer at Vittra Utbildning AB and Anew Learning AB.
He was also the Chairman at Xvivo Perfusion AB from 2012 to 2018, and the Chairman at BioLamina AB.
Additionally, he worked as the Investment Director at Bure Equity AB from 2009 to 2018, and as the Independent Director at Vitrolife AB from 2007 to 2018.
He held positions such as Director at Mercuri International Group AB and MedCap AB, and Investment Director at Bure Equity (Private Equity) from 2010 to 2018.
He also served as a Director at Energo-Retea AB, Celemiab Group AB, Theducation AB, Life Genomics AB, and Skanditek Industriförvaltning AB.
Prior to that, he was the Vice President-Homecare at Gambro Renal Products, Inc. and a Management Consultant at McKinsey & Co. Service AB.

Aktive Positionen von Hans Fredrik Mattsson

UnternehmenPositionBeginn
DEVYSER DIAGNOSTICS AB Director/Board Member 01.01.2022
Celemi International AB Chairman -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Alle aktiven Positionen von Hans Fredrik Mattsson

Ehemalige bekannte Positionen von Hans Fredrik Mattsson

UnternehmenPositionEnde
Private Equity Investor 31.10.2018
BURE EQUITY AB Chief Investment Officer 15.09.2018
XVIVO PERFUSION AB Chairman 27.04.2018
Director/Board Member 26.12.2012
░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Hans Fredrik Mattsson im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Hans Fredrik Mattsson im Detail an

Beziehungen

42

Beziehungen ersten Grades

21

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen5
BURE EQUITY AB

Finance

VITROLIFE AB

Health Technology

MEDCAP AB

Health Technology

XVIVO PERFUSION AB

Health Technology

DEVYSER DIAGNOSTICS AB

Health Technology

Private Unternehmen16

Finance

Commercial Services

Commercial Services

Finance

Commercial Services

Commercial Services

Consumer Services

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Services

Finance

Celemi International AB

Finance

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Hans Fredrik Mattsson